MRD in AML: time for redefinition of CR?
Blood
.
2013 Mar 21;121(12):2166-8.
doi: 10.1182/blood-2013-01-480590.
Authors
Gert Ossenkoppele
1
,
Gerrit Jan Schuurhuis
Affiliation
1
VU University Medical Center Amsterdam, Netherlands.
PMID:
23520326
DOI:
10.1182/blood-2013-01-480590
No abstract available
Publication types
Comment
MeSH terms
Core Binding Factors / genetics*
Female
Genes, Neoplasm*
Humans
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / pathology*
Male
Mutation*
Substances
Core Binding Factors